Ruta Graveolens

Ruta Grav


Standard Homeopathic Company
Human Otc Drug
NDC 0360-0332
Ruta Graveolens also known as Ruta Grav is a human otc drug labeled by 'Standard Homeopathic Company'. National Drug Code (NDC) number for Ruta Graveolens is 0360-0332. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Ruta Graveolens drug includes Ruta Graveolens Flowering Top - 30 [hp_X]/g . The currest status of Ruta Graveolens drug is Active.

Drug Information:

Drug NDC: 0360-0332
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Ruta Graveolens
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Ruta Grav
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Standard Homeopathic Company
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:RUTA GRAVEOLENS FLOWERING TOP - 30 [hp_X]/g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:SUBLINGUAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 17 Feb, 1997
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 19 May, 2024
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:STANDARD HOMEOPATHIC COMPANY
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0300360033213
UPC stands for Universal Product Code.
UNII:N94C2U587S
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
0360-0332-011 g in 1 BOTTLE, PLASTIC (0360-0332-01)17 Feb, 1997N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Sprains, backache or eye strain

Product Elements:

Ruta graveolens ruta grav acacia lactose monohydrate ruta graveolens flowering top ruta graveolens flowering top

Indications and Usage:

Sprains, backache or eye strain

Warnings:

Warnings do not use if cap band is missing or broken. if you are pregnant or nursing, consult a licensed health care professional before using this product. if symptoms persist for 7 days or worsen, contact a licensed practitioner. to be used according to label indications and/or standard homeopathic indications keep this and all medicines out of the reach of children.

Dosage and Administration:

Directions adults: dissolve 4 tablets under tongue 4 times a day. children: consult a healthcare professional

Package Label Principal Display Panel:

Principal display panel -- 250 tablet bottle label standard homeopathic made in the usa since 1903 ndc # 0360-0332-01 homeopathic medicine ruta grav. 30x sprains, backache or eye strain* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. 250 tablets label

Further Questions:

Standard homeopathic company los angeles, ca 90061 questions? 800-624-9659


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.